Polaris Group
Clinical trials sponsored by Polaris Group, explained in plain language.
-
New drug targets arginine to fight advanced liver cancer
Disease control Recruiting nowThis Phase 3 trial is testing whether a drug called ADI-PEG 20 can help people with advanced liver cancer that cannot be surgically removed. The study will compare the drug against a placebo in 300 participants who have high levels of a natural substance called arginine in their …
Phase: PHASE3 • Sponsor: Polaris Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial targets dangerous liver fat
Disease control Recruiting nowThis study is testing whether an investigational drug called ADI-PEG 20 can safely reduce the amount of fat in the liver of people with NASH, a serious form of fatty liver disease. About 60 adults with confirmed NASH will receive either the drug or a placebo for 24 weeks. The mai…
Phase: PHASE2 • Sponsor: Polaris Group • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC